Request Free Sample ×
High Intensity Focused Ultrasound (HIFU) Therapy Market Research Report - Forecast till 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

High Intensity Focused Ultrasound Therapy Market

ID: MRFR/MED/0383-HCR
110 Pages
Satyendra Maurya, Kinjoll Dey
Last Updated: April 28, 2026

High Intensity Focused Ultrasound Therapy Market Research Report Information By Method (Non-Invasive Method and Minimal Invasive Method), By Application (Prostate Cancer, Uterine Fibroids, Neurological Disorders, Cosmetic Medicine, and Others), By End User (Diagnostic Centers, Hospitals, Research Centers, and Others), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – HIFU Industry Forecast 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

High Intensity Focused Ultrasound Therapy Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

High Intensity Focused Ultrasound Therapy Market Summary

The Global High Intensity Focused Ultrasound Therapy Market size was valued at USD 127.05 Million in 2024, and the market is projected to grow from USD 146.75 Million in 2025 to USD 620.11 Million by 2035, registering a CAGR of 15.5% during the forecast period 2025–2035. North America led the market with over 49.98% share, generating around USD 63.5 Million in revenue.
 
Growing demand for non-invasive, precision-based treatment solutions is a key growth driver for the High Intensity Focused Ultrasound Therapy market, as it enables targeted tissue ablation, reduces surgical risks, shortens recovery time, and enhances patient outcomes across multiple therapeutic applications globally.
 
According to the World Health Organization (WHO), cancer accounts for nearly 10 million deaths annually worldwide, while noncommunicable diseases represent 74% of global mortality, significantly increasing demand for advanced, non-invasive therapies like HIFU that improve treatment precision and patient safety.

Key Market Trends & Highlights

The High Intensity Focused Ultrasound Therapy Market is poised for substantial growth driven by technological advancements and increasing demand for non-invasive treatments.

  • North America leads High Intensity Focused Ultrasound Therapy Market, accounting for over 49.98% global revenue share in 2024.
  • Europe market reached USD 44.4675 million in 2024, holding around 35% share with growing adoption of non-invasive therapies.
  • Cancer causes nearly 10 million deaths annually, significantly driving demand for precision-based, non-invasive HIFU therapy solutions globally.
  • Hospitals dominate with over 66% share in 2024, supported by advanced infrastructure and increasing adoption of innovative therapeutic technologies.

Market Size & Forecast

2024 Market Size 127.05 (USD Million)
2035 Market Size 620.11 (USD Million)
CAGR (2025 - 2035) 15.5%

Major Players

Companies such as EDAP TMS (FR), InSightec (IL), FUS Instruments (CA), SonaCare Medical (US), Focus Surgery (US), HIFU Prostate Services (US), Meridian Health (US), Chongqing Haifu Medical Technology (CN) are some of the major participants in the market.

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

High Intensity Focused Ultrasound Therapy Market Trends

The High Intensity Focused Ultrasound Therapy Market is currently experiencing a notable evolution, driven by advancements in technology and increasing awareness of non-invasive treatment options. This innovative therapy utilizes focused ultrasound waves to target and destroy tissue, offering a promising alternative to traditional surgical methods. As healthcare providers and patients alike seek less invasive solutions, the demand for High Intensity Focused Ultrasound Therapy is likely to grow. Furthermore, ongoing research and clinical trials are expanding the applications of this therapy, potentially leading to new treatment protocols and improved patient outcomes. 

In addition to technological advancements, the High Intensity Focused Ultrasound Therapy Market is influenced by a growing emphasis on personalized medicine. Tailoring treatments to individual patient needs appears to enhance efficacy and satisfaction. Moreover, the integration of artificial intelligence and machine learning into ultrasound technology may further refine treatment precision and outcomes. As the market continues to evolve, stakeholders must remain vigilant to emerging trends and innovations that could shape the future landscape of High Intensity Focused Ultrasound Therapy.

Technological Advancements

Recent innovations in ultrasound technology are enhancing the capabilities of High Intensity Focused Ultrasound Therapy. These advancements may lead to improved precision in targeting tissues, thereby increasing treatment efficacy and reducing side effects.

  • The Institute for Health Metrics and Evaluation (IHME) estimates that global disease burden continues to rise, with over 43 million deaths annually linked to chronic conditions, encouraging adoption of advanced technologies like precision ultrasound. Innovations enhancing targeting accuracy and treatment monitoring significantly improve therapeutic outcomes and reduce complications.

Growing Demand for Non-Invasive Treatments

There is a rising preference among patients and healthcare providers for non-invasive treatment options. This trend is likely to drive the adoption of High Intensity Focused Ultrasound Therapy as a viable alternative to traditional surgical procedures.

  • The Centers for Disease Control and Prevention (CDC) reports that 6 in 10 adults globally (modeled from U.S. trends) live with at least one chronic disease, increasing preference for safer, non-invasive treatment options. HIFU offers reduced recovery time and lower complication risks, supporting its expanding clinical adoption.

Integration of Artificial Intelligence

The incorporation of artificial intelligence into ultrasound systems is expected to revolutionize the High Intensity Focused Ultrasound Therapy Market. AI may facilitate better treatment planning and real-time monitoring, potentially enhancing patient outcomes.

  • UNICEF highlights that over 50% of the global population is now connected to digital technologies, accelerating adoption of AI-driven healthcare solutions. Integration of artificial intelligence in imaging and therapy planning enhances precision, enabling real-time monitoring and improved outcomes in advanced treatments like HIFU therapy.

High Intensity Focused Ultrasound Therapy Market Drivers

Technological Advancements

The Global High Intensity Focused Ultrasound Therapy Market Industry is currently experiencing rapid technological advancements that enhance treatment efficacy and patient outcomes. Innovations in ultrasound technology, such as improved imaging techniques and more precise targeting capabilities, are likely to drive market growth. 
 
For instance, the development of real-time imaging systems allows practitioners to monitor treatment progress more effectively. This not only increases the safety of procedures but also boosts patient confidence in non-invasive therapies. As a result, the market is projected to maintain a steady valuation of 0.13 USD Billion in 2024, with expectations of similar figures through 2035.

Growing Awareness and Education

The Global High Intensity Focused Ultrasound Therapy Market Industry is experiencing a surge in awareness and education regarding the benefits of ultrasound therapy. Healthcare professionals and patients alike are becoming more informed about the advantages of non-invasive treatments, leading to increased acceptance and utilization of High Intensity Focused Ultrasound Therapy Market.
 
Educational campaigns and professional training programs are instrumental in disseminating knowledge about this technology, thereby fostering its adoption in clinical settings. As awareness continues to grow, the market is likely to see sustained interest, maintaining its valuation of 0.13 USD Billion in 2024 and beyond.

Government Initiatives and Funding

The Global High Intensity Focused Ultrasound Therapy Market Industry benefits from various government initiatives aimed at promoting advanced medical technologies. Governments across the globe are increasingly investing in healthcare infrastructure and funding research and development in non-invasive treatment options. These initiatives not only enhance the availability of High Intensity Focused Ultrasound Therapy Market but also encourage clinical trials and innovation in treatment protocols.
 
Such support is likely to bolster market growth, as healthcare providers adopt these technologies to improve patient care. The market is expected to remain stable at a valuation of 0.13 USD Billion in 2024, reflecting the positive impact of these initiatives.

Rising Incidence of Chronic Diseases

The Global High Intensity Focused Ultrasound Therapy Market Industry is significantly influenced by the increasing prevalence of chronic diseases, such as cancer and cardiovascular disorders. As these conditions become more common, there is a corresponding rise in the demand for effective treatment modalities. High Intensity Focused Ultrasound Therapy Market has emerged as a promising option for targeting tumors and other pathological tissues with minimal side effects.
 
The growing patient population requiring such interventions is likely to sustain market growth. Despite the challenges posed by economic fluctuations, the market is projected to maintain its valuation of 0.13 USD Billion in 2024, with a CAGR of 0.0% anticipated from 2025 to 2035.

Increasing Demand for Non-Invasive Treatments

The Global High Intensity Focused Ultrasound Therapy Market Industry is witnessing a growing preference for non-invasive treatment options among patients. This trend is largely driven by the desire to avoid the risks and recovery times associated with traditional surgical procedures. High Intensity Focused Ultrasound Therapy Market offers a compelling alternative, providing effective treatment for various conditions, including tumors and fibroids, without the need for incisions.
 
As awareness of these benefits spreads, the market is likely to attract more patients seeking safer and less invasive options. This shift in patient preference is expected to contribute to a stable market valuation of 0.13 USD Billion in 2024.

Market Segment Insights

By Application: Tumor Ablation (Largest) vs. Pain Management (Fastest-Growing)

In the High Intensity Focused Ultrasound Therapy Market, Tumor Ablation emerges as the largest application segment with 61% market share, driven by its effectiveness in treating various tumors with precision and minimal side effects. The segment commands a significant share compared to others, reflecting its established position in clinical practices worldwide. Pain Management, while a smaller segment, is rapidly gaining traction due to an increasing demand for non-invasive treatment options as well as a growing understanding of ultrasound's analgesic capabilities. This is propelling it into the spotlight as one of the fastest-growing applications in the field.

Pain Management (Dominant) vs. Cosmetic Treatment (Emerging)

Pain Management stands out as a dominant application in the High Intensity Focused Ultrasound Therapy Market, driven by the relentless pursuit of patients seeking effective, non-invasive alternatives for chronic pain relief. This segment focuses on utilizing ultrasound technology to disrupt pain pathways without the need for surgery or long recovery times, making it appealing for both patients and healthcare providers. On the other hand, Cosmetic Treatment is an emerging application gaining momentum as consumers increasingly seek skin rejuvenation and non-invasive cosmetic procedures. The appeal lies in the technology's ability to promote collagen production and contour the skin, combining aesthetic desires with therapeutic benefits.

By End Use: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the High Intensity Focused Ultrasound Therapy Market, hospitals command the largest share of 66% due to their established infrastructures and comprehensive treatment options. They provide a wide array of services, making them primary centers for advanced medical procedures, including HIFU therapy. Ambulatory surgical centers, while smaller in share, are quickly gaining traction due to their streamlined processes and cost-management advantages, appealing to both patients and insurance providers alike.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals are the cornerstone of HIFU therapy utilization, boasting extensive resources and a vast patient base. Their ability to integrate HIFU within multiple departments enhances treatment options, solidifying their market dominance. Conversely, ambulatory surgical centers are emerging as vital players by offering minimally invasive procedures with reduced hospital stay requirements. This appeals to patients seeking convenience and faster recovery times. The shift towards outpatient care is further fueled by cost-effectiveness and technological advancements that make procedures more efficient and accessible.

By Technology: Ultrasound Imaging (Largest) vs. Focused Ultrasound Surgery (Fastest-Growing)

The High Intensity Focused Ultrasound Therapy Market is characterized by a diverse range of technologies, with Ultrasound Imaging holding a dominant position  with 63% market share among the segment values due to its widespread applicability and crucial role in diagnostics. This segment is critical for accurate treatment delivery and has garnered significant market share, attributed to advancements in imaging technology that enhance precision and efficacy. In contrast, Focused Ultrasound Surgery is emerging rapidly, recognized for its innovative approach in treating various conditions non-invasively. Its growing adoption signifies a shift towards more patient-friendly options, contributing to its rapid ascension in market share.

Technology: Ultrasound Imaging (Dominant) vs. Focused Ultrasound Surgery (Emerging)

Ultrasound Imaging, as the dominant segment in the High Intensity Focused Ultrasound Therapy Market, stands out for its essential role in guiding treatments with enhanced accuracy and visualization. The increasing preference for non-invasive procedures has led to greater investment in imaging technologies, which play a vital part in treatment planning and monitoring. On the other hand, Focused Ultrasound Surgery represents an emerging segment that is gaining traction owing to its capability to treat tumors and other conditions without the need for incisions. This method not only reduces recovery times but also improves patient outcomes, leading to its increasing recognition and utilization across medical disciplines.

By Patient Type: Adult Patients (Largest) vs. Pediatric Patients (Fastest-Growing)

In the High Intensity Focused Ultrasound Therapy Market, Adult Patients represent the largest segment, accounting for 71% of the overall market share. This segment benefits from a higher prevalence of conditions that are treatable with this therapy, such as tumors and other chronic ailments. Conversely, Pediatric Patients constitute the fastest-growing segment, attributed to an increasing focus on non-invasive treatment options that minimize risks and complications in younger populations. As healthcare advancements continue to progress, the interest in HIFU for children is rising.

Adult Patients (Dominant) vs. Pediatric Patients (Emerging)

Adult Patients are at the forefront of the High Intensity Focused Ultrasound Therapy Market, largely due to their higher occurrence of diseases amenable to HIFU treatments, such as prostate issues and various cancers. Their routine adoption of such therapies speaks to their dominance in the field. On the other hand, Pediatric Patients are emerging with growing interest in this non-invasive technology, aligning with global trends towards safer treatment alternatives for children. Healthcare practitioners are increasingly adopting HIFU in pediatric cases, driven by a need to minimize side effects and ensure better quality of life, thereby boosting this market segment.

By Procedure Type: Minimally Invasive Procedures (Largest) vs. Non-Invasive Procedures (Fastest-Growing)

In the High Intensity Focused Ultrasound Therapy Market, the market share distribution reveals a pronounced preference for Minimally Invasive Procedures as the largest segment with 58% market share. This segment continues to attract a significant portion of market interest due to its effectiveness and lower patient recovery times. Non-Invasive Procedures, while smaller in share, are witnessing a surge in popularity, capitalizing on the growing demand for less invasive medical interventions.

Minimally Invasive Procedures (Dominant) vs. Non-Invasive Procedures (Emerging)

Minimally Invasive Procedures remain a dominant force within the High Intensity Focused Ultrasound Therapy Market, characterized by their reduced recovery time and lower risk of complications compared to traditional surgical methods. These procedures leverage advanced technology to provide effective treatment with minimal disruption to the patient's daily life. On the other hand, Non-Invasive Procedures are emerging rapidly, driven by increasing patient awareness and preference for non-surgical options. This segment benefits from technological advancements that enhance the efficacy and safety of treatments, appealing to a broader audience seeking effective yet gentler medical solutions.

Get more detailed insights about High Intensity Focused Ultrasound Therapy Market
Request Free Sample

Regional Insights

North America : Market Leader in Innovation

North America leads in the High Intensity Focused Ultrasound Therapy Market size, accounting for over 49.98% of the global revenue in 2024. The region's growth is driven by increasing healthcare expenditure, technological advancements, and a rising prevalence of chronic diseases. Regulatory support from agencies like the FDA further catalyzes market expansion, ensuring that innovative therapies are swiftly approved and accessible to patients.

The competitive landscape in North America is robust, featuring key players such as SonaCare Medical, EDAP TMS, and InSightec. The U.S. stands out as the leading country, with a well-established healthcare infrastructure and a high adoption rate of advanced medical technologies. This region's focus on research and development, coupled with strategic partnerships among industry leaders, positions it favorably for sustained growth in the HIFU therapy market.

  • The Pan American Health Organization (PAHO) reports that noncommunicable diseases account for approximately 81% of all deaths in the Americas, significantly increasing demand for advanced therapeutic solutions. This supports widespread adoption of non-invasive technologies like HIFU, improving treatment outcomes and reducing healthcare system burdens.

Europe : Emerging Market with Potential

Europe High Intensity Focused Ultrasound Therapy Market size was valued at USD 44.4675 million in 2024, making it the second-largest regional market with a 35% share. Factors such as an aging population, increasing awareness of non-invasive treatment options, and supportive healthcare policies are driving demand. The European Medicines Agency (EMA) plays a crucial role in regulating and approving HIFU technologies, ensuring safety and efficacy in treatments. Leading countries in Europe include Germany, France, and the UK, where healthcare systems are increasingly integrating HIFU therapies into clinical practice. The competitive landscape features companies like EDAP TMS and InSightec, which are actively expanding their market presence. Collaborative efforts between healthcare providers and technology developers are expected to enhance the adoption of HIFU therapies across the region.

  • The European Centre for Disease Prevention and Control (ECDC) indicates that chronic diseases contribute to nearly 77% of the total disease burden in Europe, driving demand for innovative treatment approaches. HIFU therapy adoption is increasing as healthcare systems prioritize safer, efficient, and patient-friendly therapeutic solutions.

Asia-Pacific : Rapidly Growing Market

The Asia-Pacific region is emerging as a significant player in the High Intensity Focused Ultrasound (HIFU) therapy market, with a market share of 24.53% as of 2024. The growth is fueled by increasing healthcare investments, a rising prevalence of cancer, and a growing demand for non-invasive treatment options. Government initiatives aimed at improving healthcare access and affordability are also contributing to market expansion.

Countries like China, Japan, and India are leading the charge in adopting HIFU technologies. The presence of key players such as Chongqing Haifu Medical Technology and FUS Instruments enhances the competitive landscape. As healthcare infrastructure improves and awareness of HIFU benefits grows, the region is expected to see accelerated adoption of these therapies, positioning it for significant growth in the coming years.

Middle East and Africa : Emerging Market Opportunities

The Middle East and Africa (MEA) region is in the nascent stages of adopting High Intensity Focused Ultrasound (HIFU) therapy, with a market share of 3.0% as of 2024. The growth potential is driven by increasing healthcare investments, a rising prevalence of chronic diseases, and a growing interest in advanced medical technologies. Regulatory bodies in the region are beginning to recognize the importance of HIFU therapies, paving the way for future approvals and market entry.

Countries such as South Africa and the UAE are at the forefront of this emerging market, with healthcare systems gradually integrating HIFU technologies. The competitive landscape is still developing, but the presence of international players is expected to stimulate growth. As awareness and acceptance of HIFU therapies increase, the MEA region is poised for gradual yet significant advancements in this field.

High Intensity Focused Ultrasound Therapy Market Regional Image

Key Players and Competitive Insights

The High Intensity Focused Ultrasound Therapy Market is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for non-invasive treatment options. Key players such as EDAP TMS (FR), InSightec (IL), and SonaCare Medical (US) are at the forefront, each adopting distinct strategies to enhance their market presence. EDAP TMS (FR) focuses on innovation in its HIFU technology, aiming to expand its product offerings and improve treatment efficacy. In contrast, InSightec (IL) emphasizes strategic partnerships to bolster its research capabilities and market reach, while SonaCare Medical (US) is actively pursuing regional expansion to tap into emerging markets, thereby shaping a competitive environment that is increasingly collaborative yet competitive.
 
The market structure appears moderately fragmented, with several players vying for market share through various business tactics. Localizing manufacturing and optimizing supply chains are prevalent strategies among these companies, allowing them to reduce costs and enhance service delivery. The collective influence of these key players fosters a competitive atmosphere where innovation and operational efficiency are paramount, driving the market forward.
 
In November EDAP TMS (FR) announced a strategic partnership with a leading healthcare provider to enhance the accessibility of its HIFU technology in Europe. This collaboration is expected to facilitate the integration of advanced treatment protocols, thereby increasing patient access and potentially boosting revenue streams. Such partnerships are indicative of a broader trend towards collaborative innovation in the market.
 
In October InSightec (IL) launched a new clinical trial aimed at evaluating the efficacy of its Exablate Neuro system for treating neurological disorders. This initiative not only underscores the company's commitment to expanding its therapeutic applications but also positions it as a leader in the integration of HIFU technology within neurology. The outcomes of this trial could significantly influence future treatment paradigms and market dynamics.
 
In September SonaCare Medical (US) unveiled a new training program for healthcare professionals focused on the latest advancements in HIFU techniques. This initiative is crucial for enhancing the skill set of practitioners, ensuring that they are well-equipped to utilize the technology effectively. By investing in education and training, SonaCare Medical (US) is likely to strengthen its market position and foster greater adoption of its products.
 
As of December current competitive trends in the High Intensity Focused Ultrasound Therapy Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI). Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation. The competitive differentiation is expected to evolve, shifting from price-based competition to a focus on technological advancements, innovative treatment solutions, and reliable supply chains. This transition suggests that companies that prioritize R&D and strategic partnerships will likely emerge as leaders in this evolving landscape.

Key Companies in the High Intensity Focused Ultrasound Therapy Market include

Industry Developments

  • Q2 2024: EDAP TMS Receives FDA 510(k) Clearance for Focal One® Robotic HIFU System for Prostate Tissue Ablation EDAP TMS announced it received FDA 510(k) clearance for its Focal One® Robotic High Intensity Focused Ultrasound (HIFU) system, allowing its use for prostate tissue ablation in the United States.
  • Q2 2024: Insightec Announces FDA Approval of Exablate Prostate for Treatment of Prostate Disease Insightec received FDA approval for its Exablate Prostate system, a high intensity focused ultrasound device for the treatment of prostate disease, expanding its clinical indications in the U.S.
  • Q2 2024: Sonablate Corp. Announces Strategic Partnership with Siemens Healthineers to Advance HIFU Technology Sonablate Corp. entered a strategic partnership with Siemens Healthineers to integrate HIFU technology with advanced imaging solutions, aiming to enhance precision in non-invasive therapies.
  • Q3 2024: Theraclion Raises €10 Million in Series C Funding to Accelerate HIFU Platform Development Theraclion, a French medtech company specializing in HIFU, closed a €10 million Series C funding round to support the development and commercialization of its next-generation HIFU platforms.
  • Q3 2024: EDAP TMS Announces Opening of New Manufacturing Facility in Lyon, France EDAP TMS inaugurated a new manufacturing facility in Lyon to expand production capacity for its HIFU devices, supporting growing global demand.
  • Q3 2024: Haifu Medical Receives CE Mark for New HIFU System for Uterine Fibroids Haifu Medical obtained CE Mark approval for its latest high intensity focused ultrasound system designed for the non-invasive treatment of uterine fibroids in Europe.
  • Q4 2024: Profound Medical Announces First Patient Treated in Pivotal TULSA-PRO® HIFU Study for Prostate Cancer Profound Medical announced the treatment of the first patient in its pivotal clinical study evaluating the TULSA-PRO® HIFU system for whole-gland ablation of prostate cancer.
  • Q4 2024: Insightec and Mayo Clinic Expand Collaboration to Advance HIFU for Neurological Disorders Insightec and Mayo Clinic expanded their collaboration to further research and clinical adoption of HIFU for the treatment of neurological disorders, including essential tremor and Parkinson’s disease.
  • Q1 2025: EDAP TMS Appoints New Chief Commercial Officer to Drive Global HIFU Expansion EDAP TMS appointed a new Chief Commercial Officer to lead the company’s global commercial strategy and accelerate the adoption of its HIFU technologies.
  • Q1 2025: Theraclion Signs Distribution Agreement with Medtronic for HIFU Systems in Asia-Pacific Theraclion entered into a distribution agreement with Medtronic to market and distribute its HIFU systems across the Asia-Pacific region.
  • Q2 2025: Profound Medical Receives Health Canada Approval for TULSA-PRO® HIFU System Profound Medical received regulatory approval from Health Canada for its TULSA-PRO® HIFU system, enabling commercialization for prostate disease treatment in Canada.
  • Q2 2025: EDAP TMS Announces Strategic Partnership with Philips to Integrate HIFU with Advanced Imaging EDAP TMS announced a strategic partnership with Philips to integrate its HIFU technology with Philips’ advanced imaging platforms, aiming to improve treatment precision and outcomes.

Future Outlook

High Intensity Focused Ultrasound Therapy Market Future Outlook

The High Intensity Focused Ultrasound Therapy Market is projected to grow at a 15.5% CAGR from 2025 to 2035, driven by technological advancements and increasing demand for non-invasive treatments.

New opportunities lie in:

  • Development of portable ultrasound devices for outpatient settings. Strategic partnerships with healthcare providers for integrated treatment solutions. Expansion into emerging markets with tailored service offerings.

By 2035, the market is expected to solidify its position as a leader in non-invasive therapeutic solutions.

Market Segmentation

High Intensity Focused Ultrasound Therapy Market End Use Outlook

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Research Institutions

High Intensity Focused Ultrasound Therapy Market Technology Outlook

  • Ultrasound Imaging
  • Thermal Ablation
  • Non-Thermal Ablation
  • Focused Ultrasound Surgery

High Intensity Focused Ultrasound Therapy Market Application Outlook

  • Tumor Ablation
  • Pain Management
  • Cosmetic Treatment
  • Neurological Disorders
  • Cardiovascular Disorders

High Intensity Focused Ultrasound Therapy Market Patient Type Outlook

  • Adult Patients
  • Pediatric Patients
  • Geriatric Patients
  • Pregnant Patients

High Intensity Focused Ultrasound Therapy Market Procedure Type Outlook

  • Minimally Invasive Procedures
  • Non-Invasive Procedures
  • Outpatient Procedures

Report Scope

MARKET SIZE 2024 127.05(USD Million)
MARKET SIZE 2025 146.75(USD Million)
MARKET SIZE 2035 620.11(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 15.5% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled EDAP TMS (FR), InSightec (IL), FUS Instruments (CA), SonaCare Medical (US), Focus Surgery (US), HIFU Prostate Services (US), Meridian Health (US), Chongqing Haifu Medical Technology (CN)
Segments Covered Application, End Use, Technology, Patient Type, Procedure Type
Key Market Opportunities Advancements in non-invasive treatment technologies enhance patient acceptance in the High Intensity Focused Ultrasound Therapy Market.
Key Market Dynamics Technological advancements and regulatory changes drive growth in the High Intensity Focused Ultrasound Therapy market.
Countries Covered North America, Europe, APAC, South America, MEA

Market Highlights

FAQs

What is the projected market valuation for High Intensity Focused Ultrasound Therapy by 2035?

The projected market valuation for High Intensity Focused Ultrasound Therapy is expected to reach 620.11 USD Million by 2035.

What was the market valuation for High Intensity Focused Ultrasound Therapy in 2024?

The overall market valuation for High Intensity Focused Ultrasound Therapy was 127.05 USD Million in 2024.

What is the expected CAGR for the High Intensity Focused Ultrasound Therapy market during the forecast period 2025 - 2035?

The expected CAGR for the High Intensity Focused Ultrasound Therapy market during the forecast period 2025 - 2035 is 15.5%.

Which companies are considered key players in the High Intensity Focused Ultrasound Therapy market?

Key players in the High Intensity Focused Ultrasound Therapy market include EDAP TMS, InSightec, FUS Instruments, SonaCare Medical, HIFU Prostate Services, Focus Surgery, Mermaid Medical, and Chongqing Haifu Medical Technology.

What are the main applications of High Intensity Focused Ultrasound Therapy?

The main applications of High Intensity Focused Ultrasound Therapy include Tumor Ablation, Pain Management, Cosmetic Treatment, Neurological Disorders, and Cardiovascular Disorders.

How does the market for High Intensity Focused Ultrasound Therapy segment by end use?

The market segments by end use include Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Research Institutions.

What are the different technologies used in High Intensity Focused Ultrasound Therapy?

The technologies used in High Intensity Focused Ultrasound Therapy include Ultrasound Imaging, Thermal Ablation, Non-Thermal Ablation, and Focused Ultrasound Surgery.

How is the High Intensity Focused Ultrasound Therapy market segmented by patient type?

The market segments by patient type include Adult Patients, Pediatric Patients, Geriatric Patients, and Pregnant Patients.

What types of procedures are included in the High Intensity Focused Ultrasound Therapy market?

The types of procedures included in the market are Minimally Invasive Procedures, Non-Invasive Procedures, and Surgical Procedures.

What was the valuation range for Tumor Ablation in the High Intensity Focused Ultrasound Therapy market?

The valuation range for Tumor Ablation in the High Intensity Focused Ultrasound Therapy market was between 30.0 and 150.0 USD Million.
Author
Author
Author Profile
Satyendra Maurya LinkedIn
Research Analyst
An accomplished research analyst with high proficiency in market forecasting, data visualization, competitive benchmarking, and others. He holds a pronounced track record in research and consulting projects for sectors such as life sciences, medical devices, and healthcare IT. His capabilities in qualitative and quantitative analysis have resulted in positive client outcomes. Working on niche market trends, opportunities, sales, and forecasted value is part of his skill set.
Co-Author
Co-Author Profile
Kinjoll Dey LinkedIn
Senior Research Analyst
He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get In Touch
Leave a Comment
Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓